Prevalence of the main ophthalmic diseases and focus on diabetic retinopathy and age related macular degeneration. Overview of actual findings and design.

Slides:



Advertisements
Similar presentations
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.
Advertisements

In Search of Efficiency, Consistency, Fairness, and Impact in HTA: Modelling screening and treatment pathways for diabetic retinopathy Graham Scotland.
DIABETES AND THE EYE. EPIDEMIOLOGY Commonest cause of blindness in the population of working age in developed countries Prevalence of DR of any severity.
Together for Eye Health Care National Eye Health Care Service Plan for Wales 2012 – 2017 Dr Barbara Ryan Cheif Optometric Advisor.
Minimum Data Set Serge Resnikoff MD, PhD Course 5 Data Collection and Information Management.
Gwyneth Thomas, Health Statistics and Analysis, Welsh Government Chair of Together for Health: Eye Health Care Delivery Plan Statistics Group Statistical.
Cataract in the 21st century Liana Al-Labadi, O.D. Lecture 6 Thanks To The Ohio State College of Optometry.
REFERENCES 1.Roberts E, Morgan R, King D, Clerkin L. Funduscopy: a forgotten art? Postgrad Med J. 1999; 75: McComiskie JE, Greer RM, Gole GA.
Meeting with European institutions 1 st April #ECVeyehealthEU.
Prospective Telemedicine Screening for Diabetics at High Risk for Retinopathy. PI- Jayne S Weiss, MD LSUHSC-NO.
1 Supporting people living with dementia and serious sight loss. Catherine Dennison - Thomas Pocklington Trust Rebecca Sheehy - RNIB Mr Paul G Ursell MBBS.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
Diabetic Retinopathy: A technological and innovative intervention to improve detection of target organ damage S. Naidu, MD, MPH, FAAFP Medical Director.
Ayesha Abdullah By the end of this lecture the students should be able to: Define blindness, visual impairment & low vision according.
WHY CARE ABOUT YOUR EYES? Brought to you by the Centre for Healthy Aging at Providence and CNIB An Eye Health Information Session.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Ophthalmology in Malawi DR JOSEPH MSOSA.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
Committed to excellence in eye care Smoking Cessation Services in High Street Optometric Practices.
The Challenge of Vision Loss: The Need for Advocacy
6-year vision loss in patients newly diagnosed with clinical type 2 diabetes. What can the patients expect? Niels de Fine Olivarius Volkert Siersma Gitte.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Europe Ophthalmic Viscosurgical Devices Market to hit $230mn by 2024.
Prevalence of Diabetic Retinopathy
Age-related macular degeneration: an update
Vision Care : A Core Workplace Benefit
Clinical Audit Assessment of compliance to follow-up schedule following PRP in patients with Proliferative Diabetic Retinopathy Department of Retina and.
Reproducibility of retinal thickness measurements in eyes with
OCULAR FINDINGS OF SCHOOL SCREENING AND EYE CAMP IN NEPAL
Using Clinformatics Data Mart Data to Learn About Patients with Ocular Diseases Joshua D. Stein, MD, MS Associate Professor University of Michigan Dept.
Ocular Manifestations of Diabetes
DIABETIC RETINOPATHY SCREENING
Understanding Barriers to Access to Eye Care in Western India
Ayesha Abdullah
Mumbaieyecarecornealasik.com.
DIABETETIC RETINOPATHY & GLAUCOMA COSI MEETING
Purpose Results Results Methods Conclusion
Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Year 1 Results Lisa A. Hark, PhD, RD; Michael Waisbourd, MD; Kamran Rahmatnejad, MD;
Asel Ryskulova, MD, MPH Richard Klein, MPH Mary Frances Cotch, PhD
Beneath seeing the surface is essential ...to the health of your eyes.
Introduction Methods Results Conclusions References
OMICS Journals are welcoming Submissions
Dr. Christine Buono MD Ophthalmology
CURRENT TREND OF DIABETIC FOOT SURGERY IN GENERAL HOSPITAL OF KSA: ARE WE DOING ENOUGH TO AVOID AMPUTATIONS? Dr. Anthony Morgan, Dr. Adel Mohammad bin.
US Medical Professionals’ Knowledge of the Diabetes Control and Complications Trial Austin Bach, DO, MPH, Mohamad ElChurafa, BS, Daniel Solano, DO, Marcos.
References: Available upon request
Bashir Dodo Automated Layer Segmentation of Macula SD-OCT Images Using Graph-Cut Method Bashir I. Dodo, Yongmin Li, Khalid.
1.03 Healthcare Trends.
Caring Your Vision - Special Aspects
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
JAMA Ophthalmology Journal Club Slides: Validity of the Age-Related Eye Disease Study Grading Scale Vitale S, Clemons TE, Agrón E, et al; Age-Related Eye.
1.03 Healthcare Trends.
DIABETES AND THE EYE.
Sarosh A. Janjua MD1, Sandra L. Cremers MD FACS1
Sight Loss and Vision Priority Setting Partnership
Ophthalmology: State of the Nation (Wales)
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Richard Clark Senior Retinal Screener NHS Tayside August 2007
Aneurin Bevan University Health Board
IoT adoption strategy in a hospital environment
1.03 Healthcare Trends.
Lorna Perez, Ethan Gough
Percentage of total eye injection procedures in Hospital Episode Statistics admitted patients care for different primary diagnoses, England, 2008/2009–2014/2015. AMD, age-related.
DEFINITION OF BLINDNESS- REVIEW
1.03 Healthcare Trends.
1.03 Healthcare Trends.
Megan Eguchi, MPh Sana karam, md, phd
Timely Access to Health Care Minister George Abbott Ministry of Health Government of British Columbia.
Visual impairment Dr Niloofar Motamed Community Medicine Internship- ICOPE-BPUMS 4/22/2019.
Strengthening eye health delivery in local health system
Presentation transcript:

Prevalence of the main ophthalmic diseases and focus on diabetic retinopathy and age related macular degeneration. Overview of actual findings and design of the epidemiological EPIGOAL Study. Giulia Mandelli MD, Luca Boerci MD, Sonia Palmieri MD, Danilo Mazzacane MD. SETTING: The epidemiological Study named “EPIGOAL Study” were managed by Outpatient eye specialists working in Milan and its province belonging to the GOAL group (Gruppo Oculisti Ambulatoriali Liberi). METHODS: Daily records from a total of 13190 patients (from March 2014 to December 2014) were collected on standardised data sheet that reports the main representative ocular pathologies (Fig.1). The pathologies were clustered and splitted as follows: Ocular surface, Glaucoma, Posterior segment and Patients who underwent surgical procedures. Furthermore taking in account the results from the analysis of those data a new data sheet were setted to collect data from 2608 patients affected by retinal disease such as Age related Macular Degeneration (AMD) and Diabetic retinopathy (DR) (from March 2015 to December 2015) (Fig.2). For the diabetic retinophaty were evaluated how many patients were affected by the Proliferative form and how many patients form the Non-proliferative form (Fig.3). About the Age related macular degeneration we divided the patients by using the Wisconsin grade scale for the severity of the disease (From Category 1 to 4- AREDS study) (Fig.4). RESULTS: From the analysis of the data collected on 2014 we found that on 13190 patients the 28% were affected by pathologies related to the anterior segment, 27% refractive errors, 12% glaucoma, 17% pathologies related to the posterior side of the eye and 16% were patients that underwent to surgical procedure. The analysis performed on 2015 focalized on the diabetic retinopathy and on AMD showed that on 2608 patients evaluated 927 (35.5%) were affected by Diabetic Retinopathy and 1681 (64.5%) by AMD. Specifically in the cluster of patients with DR, the 81% were represented by the proliferative form and the 19% by the Non-proliferative. In the AMD group a 36% were those patients belonging to the Category 2 form (Early AMD), 30% to the Category 3(Intermediate AMD) and 34% to the Category 4 (Advanced AMD) CONCLUSION: The EPIGOAL Study, conducted by the Outpatient specialists, represents the first epidemiological study on the national area to establish the prevalence of the main ocular diseases, focalizing the attention on DR and AMD . The principal aim was to define, on a big cluster of patients, which are the general characteristic of this patients to develop an effective primary and secondary prevention plan. FINAL DISCOSURES: There are no financial interests.

Figure 1. Percentage of the different ophthalmic diseases revealed on a cluster of 13190 patients screened from March 2014 to December 2014 13190 patients evaluated Prevalence of the main ophthalmic diseases and focus on diabetic retinopathy and age related macular degeneration. Overview of actual findings and design of the epidemiological EPIGOAL Study. Giulia Mandelli MD, Luca Boerci MD, Sonia Palmieri MD, Danilo Mazzacane MD.

Figure 2 shows the percentage of Age related Macular Degeneration (AMD) and Diabetic retinopathy (DR) on 2608 affected by retinal diseases screened from March 2015 to December 2015 2608 patients evaluated 927 Diabetic Retinopathy 1681 AMD Prevalence of the main ophthalmic diseases and focus on diabetic retinopathy and age related macular degeneration. Overview of actual findings and design of the epidemiological EPIGOAL Study. Giulia Mandelli MD, Luca Boerci MD, Sonia Palmieri MD, Danilo Mazzacane MD.

Figure 3 shows for the diabetic retinophaty how many patients were affected by the Proliferative form and how many patients form the Non-proliferative form. 927 patients with DR 751 Non Proliferative 176 Proliferative Prevalence of the main ophthalmic diseases and focus on diabetic retinopathy and age related macular degeneration. Overview of actual findings and design of the epidemiological EPIGOAL Study. Giulia Mandelli MD, Luca Boerci MD, Sonia Palmieri MD, Danilo Mazzacane MD.

Figure 4 shows for the Age related macular degeneration how many patients with this pathology, by using the Wisconsin grade scale for the severity of the disease, belong to the different scale degree. 1681 patients with AMD 600 EARLY cat 2 512 INTERMEDIATE cat 3 569 ADVANCED cat 4 Prevalence of the main ophthalmic diseases and focus on diabetic retinopathy and age related macular degeneration. Overview of actual findings and design of the epidemiological EPIGOAL Study. Giulia Mandelli MD, Luca Boerci MD, Sonia Palmieri MD, Danilo Mazzacane MD.

GENERAL CONCLUSION The Italian National Health Service boasts a dense network of healthcare professionals. Specifically, the ophthalmologists, take care of patients of all ages with various eye diseases and refractive errors. Until now there is no national database that analyse the number and variety of diseases faced daily by the ophthalmologists that operate on the outpatients public clinics. The aim of the study was to analyse the main ocular diseases (in terms of impact on the general population) to develop an effective primary and secondary prevention plan.